References
- Kim HJ, Ko YH, Kim JE, et al., Hematopathology Study Group of the Korean Society of Pathologists. Epstein-Barr virus-associated lymphoproliferative disorders: review and update on 2016 WHO Classification. J Pathol Transl Med. 2017;51(4):352–358.
- Cohen JI, Iwatsuki K, Ko YH, et al. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting. Leuk Lymphoma 2020;61(4):808–819.
- Quintanilla-Martinez L, Ko Y-H, Kimura H, et al. EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon, France: IARC; 2017. p. 358–360.
- Expanded access protocol for Tabelecleucel for patients with Epstein-Barr virus-associated viremia or malignancies. [cited 2020 April 04]. Available from: https://clinicaltrials.gov/ct2/show/NCT02822495.
- Aguilera NS, Auerbach A. T-cell lymphoproliferative processes in the spleen. Semin Diagn Pathol. 2020;37(1):47–56.
- Hue SS, Oon ML, Wang S, et al Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach. Pathology 2020;52(1):111–127.
- Kim WY, Montes-Mojarro IA, Fend F, et al. Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases. Front Pediatr. 2019;7:71.